Do You Suffer From Migraines? Investigational Treatment May Help

Please note: This trial has finished recruiting and is not accepting new participants.

Research Centre: CTI Clinical Research Center
Location: 1775 Lexington Ave, Suite 200, Cincinnati, OH
Lead Doctor: Dr Stephen J. Poland
Ethics Committee: This study has been reviewed and approved by the Schulman Institutional Review Board

Researcher interview:

Background

Over 30 million Americans suffer from migraines. Migraine is a debilitating disorder which includes throbbing headaches sometimes accompanied by nausea, vomiting and sensitivity to light and sound.

This research study is testing a new investigational drug for the treatment of migraine symptoms.

This study seeks men and women who currently suffer from migraines. Participants are required to attend 3 study visits at the research site over 3 months and may be compensated up to $455 for participating in this study.

Benefits to Participation

  • You may be compensated up to $455 for participating in this study.
  • You may be helping to advance medical research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Men and women aged 18+ who suffer from migraines for more than 1 year
  • Experience about 2 – 8 migraines per month
  • Otherwise healthy
  • Able to attend 3 study visits at the research site over approximately 3 months

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial